Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
IT
Archived
•
September 23, 2026
•
8 views
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Source: TechCrunch | https://techcrunch.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



